Bluesky Facebook Reddit Email

Myelodysplastic syndrome with CD34+ micromegakaryocytes and giant platelets in peripheral blood

06.28.26 | Xia & He Publishing Inc.

Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

Myelodysplastic syndromes (MDS) are a group of hematopoietic disorders characterized by ineffective hematopoiesis, with manifestations of cytopenias in one, two, or three lineages. CD34 + micromegakaryocytes and giant platelets are very rarely seen in MDS patients but may lead to unnecessary treatments. Therefore, we report and follow up on an MDS case with such an unusual finding.

A 57-year-old male veteran with a history of MDS, alcoholic cirrhosis, and portal hypertension presented to the Emergency Department in 2020 for evaluation after a blackout, at which time peripheral blood samples and bone marrow biopsies were obtained. Flow cytometry analysis of his peripheral blood detected 8% CD34 + cells. This finding raised the possibility of acute leukemic transformation from MDS. Further studies revealed that these CD34 + cells represented dysplastic micromegakaryocytes and giant platelets rather than blasts. During his 4-year follow-up, the patient was alive and complained only of easy fatigability, lasting several weeks. His laboratory results showed pancytopenia and persistent iron-deficiency anemia.

The finding of CD34 + dysplastic giant platelets in our case is unusual. Such findings could lead to misdiagnosis of acute leukemia. It is important for pathologists to integrate morphologic and flow cytometric findings for overall diagnosis. This will help prevent overdiagnosis of acute leukemia in MDS patients. Furthermore, studying the population and behavior of CD34 + dysplastic platelets in MDS is valuable and may improve understanding of disease pathology.

Full text

https://www.xiahepublishing.com/2771-165X/JCTP-2026-00012

The study was recently published in the Journal of Clinical and Translational Pathology .

Journal of Clinical and Translational Pathology (JCTP) is the official scientific journal of the Chinese American Pathologists Association (CAPA). It publishes high quality peer-reviewed original research, reviews, perspectives, commentaries, and letters that are pertinent to clinical and translational pathology, including but not limited to anatomic pathology and clinical pathology. Basic scientific research on pathogenesis of diseases as well as application of pathology-related diagnostic techniques or methodologies also fit the scope of the JCTP.

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.

Journal of Clinical and Translational Pathology

10.14218/JCTP.2026.00012

Myelodysplastic Syndrome with CD34+ Micromegakaryocytes and Giant Platelets in Peripheral Blood: A Case Report

Keywords

Article Information

Contact Information

Shelly Zhang
Xia & He Publishing Inc.
service@xiahepublishing.com

Source

How to Cite This Article

APA:
Xia & He Publishing Inc.. (2026, June 28). Myelodysplastic syndrome with CD34+ micromegakaryocytes and giant platelets in peripheral blood. Brightsurf News. https://www.brightsurf.com/news/LRD09W58/myelodysplastic-syndrome-with-cd34-micromegakaryocytes-and-giant-platelets-in-peripheral-blood.html
MLA:
"Myelodysplastic syndrome with CD34+ micromegakaryocytes and giant platelets in peripheral blood." Brightsurf News, Jun. 28 2026, https://www.brightsurf.com/news/LRD09W58/myelodysplastic-syndrome-with-cd34-micromegakaryocytes-and-giant-platelets-in-peripheral-blood.html.